(Q39665768)

13 September 2017

1 reference

title

Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia (English)

1 reference

13 September 2017

0 references

Moldawer LL

1

1 reference

13 September 2017

Georgieff M

series ordinal

2

1 reference

13 September 2017

Lundholm K

series ordinal

3

1 reference

13 September 2017

publication date

1 August 1987

1 reference

13 September 2017

1 reference

13 September 2017

volume

7

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

263-274

1 reference

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Fever: The Old and the New

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Cachectin and tumour necrosis factor as two sides of the same biological coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Generalized perturbations in host physiology caused by localized tumors. Tumors and fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Total parenteral nutrition in the cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Increased plasma interleukin-1 activity in women after ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Interleukin-1 and the Pathogenesis of the Acute-Phase Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Interleukin-1 stimulation of astroglial proliferation after brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Effect of indomethacin on proteolysis in septic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Studies of endotoxin-induced decrease in lipoprotein lipase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Antiviral effects of recombinant tumour necrosis factor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

A rationale for administering leukocyte endogenous mediator to protein malnourished, hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Control of food intake in cancer cachexia: a challenge and a tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Tumor necrosis factor (TNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Regulation of class III major histocompatibility complex gene products by interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Pyrexia in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Shock and tissue injury induced by recombinant human cachectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

Leukocyte endogenous mediator alters protein dynamics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.1987.TB00169.X

10.1111/J.1475-097X.1987.TB00169.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference